The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

Share Price Information for Jaywing (JWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.10
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.10 (3.226%)
Open: 3.15
High: 3.15
Low: 3.15
Prev. Close: 3.15
JWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity & PDMR Dealings

6 Dec 2016 10:05

RNS Number : 0843R
Jaywing PLC
06 December 2016
 

Date: Tuesday 6th December 2016

On behalf of: Jaywing plc ("the Company" or "the Group")

 

Jaywing plc

("Jaywing" or "the Company")

Exercise of options

Issue of equity

and

PDMR notification

 

Jaywing plc (AIM: JWNG), announces that options to subscribe for 350,513 ordinary shares of £0.05 each in the Company have today been exercised by certain employees. These options were previously granted to employees under the Company's Performance Share Plan.

Chris Hancock, MD Contact, Ben O'Brien, MD Data Science, Brian Taylor, MD Digital Marketing, and Tom Salmon, MD Epiphany, who are each considered to be persons discharging managerial responsibilities (PDMRs), have exercised options over 17,828 ordinary shares, 37,000 ordinary shares, 61,000 ordinary shares, and 52,070 ordinary shares respectively.

The remaining options over 182,615 ordinary shares have been exercised by other members of staff.

Pursuant to the exercise of the options, an application has been made to the London Stock Exchange for 350,513 new ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective on 9 December 2016.

Following Admission, the Company will have 86,709,898 ordinary shares in issue admitted to trading on AIM.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Chris Hancock

2. Ben O'Brien

3. Brian Taylor

4. Tom Salmon

2

Reason for the notification

a)

Position/status

1. Managing Director & PDMR

2. Managing Director & PDMR

3. Managing Director & PDMR

4. Managing Director & PDMR

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Jaywing plc

b)

LEI

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.05 each

 

ISIN: GB00B1FPT10

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 Price

No. of shares

1. £0.05

2. £0.05

3. £0.05

4. £0.05

1. 17,828

2. 37,000

3. 61,000

4. 52,070

d)

Aggregated information

- Aggregated volume

- Price

Volume: 350,513

Weighted average price: £0.05

 

e)

Date of the transaction

6 December 2016

f)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:Jaywing plcMichael Sprot (Company Secretary) Tel: 0114 281 1200

 

Cenkos Securities plc

Ivonne Cantu/Callum Davidson(Nomad) Tel: 0207 397 8920

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCAKADKKBDDQBK
Date   Source Headline
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)
26th Aug 202211:10 amRNSAcquisition of Midisi Limmited
24th Aug 20227:00 amRNSAppointment of CFO
11th Aug 20227:00 amRNSTrading Update
14th Mar 20227:00 amRNSDirectorate Change
7th Dec 20217:00 amRNSHalf-year Report
3rd Nov 202110:30 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSDirectorate Change
2nd Nov 20217:00 amRNSUpdate re. Frank Digital
21st Sep 20214:43 pmRNSHolding(s) in Company
21st Sep 20213:51 pmRNSResult of AGM
25th Aug 20212:49 pmRNSFinal Results - Replacement
25th Aug 20217:00 amRNSFinal Results
16th Jul 20217:00 amRNSContract win
21st Apr 20213:03 pmRNSDirectorate Change
3rd Feb 20213:45 pmRNSHolding(s) in Company
23rd Dec 202011:54 amRNSResult of General Meeting
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.